T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Roper Technologies
ROP
$39.9B
| $3.58B | 0.61% |
14,695,590
-693,540
| -5% | -$163M |
|
27
Intuit
INTU
$91.5B
| $3.44B | 0.59% |
24,226,329
+4,213,869
| +21% | +$582M |
|
|
AET
28
DELISTED
Aetna Inc
AET
| $3.39B | 0.58% |
21,313,237
-283,924
| -1% | -$44.4M |
|
29
American Airlines Group
AAL
$9.93B
| $3.38B | 0.58% |
71,158,129
+7,655,385
| +12% | +$370M |
|
30
Biogen
BIIB
$30.6B
| $3.34B | 0.57% |
10,681,378
+1,732,596
| +19% | +$513M |
|
|
AMTD
31
DELISTED
TD Ameritrade Holding Corp
AMTD
| $3.33B | 0.57% |
68,171,477
+6,533,331
| +11% | +$293M |
|
32
Cigna
CI
$73.6B
| $3.19B | 0.55% |
17,088,527
+1,151,213
| +7% | +$205M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.13B | 0.53% |
22,281,648
-537,207
| -2% | -$73M |
|
34
ExxonMobil
XOM
$662B
| $3.06B | 0.52% |
37,293,429
+5,947,607
| +19% | +$472M |
|
35
State Street
STT
$51.3B
| $3.03B | 0.52% |
31,689,052
-1,693
| -0% | -$158K |
|
36
Citigroup
C
$227B
| $2.99B | 0.51% |
41,107,593
+449,742
| +1% | +$30.7M |
|
37
American Tower
AMT
$78.8B
| $2.93B | 0.5% |
21,426,241
-4,119,688
| -16% | -$574M |
|
|
MRSH
38
Marsh
MRSH
$91B
| $2.92B | 0.5% |
34,865,891
-1,531,943
| -4% | -$121M |
|
|
39
Crown Castle
CCI
$31.3B
| $2.88B | 0.49% |
28,852,393
+15,478,096
| +116% | +$1.58B |
|
|
EA
40
DELISTED
Electronic Arts
EA
| $2.86B | 0.49% |
24,265,959
+1,605,858
| +7% | +$186M |
|
41
Intercontinental Exchange
ICE
$84.5B
| $2.82B | 0.48% |
41,115,261
+1,411,736
| +4% | +$93M |
|
42
PG&E
PCG
$37.5B
| $2.77B | 0.47% |
40,738,611
-636,386
| -2% | -$43.6M |
|
43
Elevance Health
ELV
$86.2B
| $2.74B | 0.47% |
14,449,618
+903,197
| +7% | +$172M |
|
44
Tyson Foods
TSN
$20.1B
| $2.69B | 0.46% |
38,251,251
+3,081,176
| +9% | +$197M |
|
45
Comcast
CMCSA
$89.4B
| $2.59B | 0.44% |
67,256,076
+8,474,578
| +14% | +$334M |
|
46
Netflix
NFLX
$318B
| $2.53B | 0.43% |
139,588,270
+33,165,430
| +31% | +$578M |
|
|
BNY
47
Bank of New York Mellon
BNY
$108B
| $2.52B | 0.43% |
47,561,689
+259,750
| +0.5% | +$13.6M |
|
48
Yum! Brands
YUM
$39.7B
| $2.5B | 0.43% |
33,954,933
+8,018,542
| +31% | +$603M |
|
49
Johnson & Johnson
JNJ
$631B
| $2.48B | 0.42% |
19,059,893
-2,611,213
| -12% | -$346M |
|
50
Fidelity National Information Services
FIS
$21.9B
| $2.46B | 0.42% |
26,352,710
+5,164,347
| +24% | +$469M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.